Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary TuberculosisChandrasekaran Padmapriydarsini, Megha Mamulwar, Anant Mohan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2026
Association of Mycobacterium Avium paratuberculosis with Crohn's Disease: A large multicentre study from TB endemic regionSudheer Kumar Vuyyuru, Urvashi Singh, Prasenjit Das, et al.
Open Forum Infectious Diseases|July 23, 2025
Operational Feasibility of "TB Concentration & Transport" and "TB DNA Extraction" Kits for Biosafe Dry Sputum Transport for Direct Detection of Drug Resistance Using Line Probe Assay: A Field Study in IndiaKeerti Chauhan, Rakesh Kumar Gupta, Divya Anthwal, et al.
Memorias Do Instituto Oswaldo Cruz|March 19, 2020
Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysisKamaiaji Castor, Fabio Batista Mota, Roseli Monteiro da Silva, et al.
Plos One|March 3, 2023
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitorRajesh Mondal, Azger Dusthackeer V N, Palaniyandi Kannan, et al.
The European Respiratory Journal|May 29, 2021
A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assaysAdam Penn-Nicholson, Sivaramakrishnan N Gomathi, Cesar Ugarte-Gil, et al.
Infectious Diseases (London, England)|August 16, 2024
Operational feasibility and multi-centric evaluation of 'TBDetect sputum microscopy kit' for the direct detection of Mycobacterium tuberculosis in field settingsKeerti Chauhan, Rakesh Kumar Gupta, Divya Anthwal, et al.
The Indian Journal of Medical Research|August 22, 2025
Multicentric validation of the PathoDetect™ MTB RIF & INH assay for simultaneous detection of Mycobacterium tuberculosis, & drug resistance to rifampicin & isoniazid in presumptive pulmonary tuberculosis & drug-resistant TB patientsHansraj Choudhary, Garima Malik, Devendra Singh Chauhan, et al.
Open Forum Infectious Diseases|March 6, 2024
Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled TrialBhavani Perumal Kannabiran, Natarajan Alangudi Palaniappan, Tamizhselvan Manoharan, et al.
The Indian Journal of Tuberculosis|July 15, 2026
Prevalence of Tuberculosis and Latent TB infection and its associated factors among rickshaw drivers; opportunities and challenges of a structured active case finding intervention at New Delhi, IndiaShikha Dhawan, Kamal Kishore Chopra, Zeeshan Sidiq, et al.
Pageof 7